BNP Paribas’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BNP Paribas's AMGN Position: Q2 2026 in Review
BNP Paribas reduced its Amgen (AMGN) stake by 17% in Q2 2026, selling an estimated $3.06M and leaving 44,979 shares worth $16.3M. The position accounts for 0.44% of the portfolio, ranked #44.
BNP Paribas first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $19M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- BNP Paribas held 44,979 shares of Amgen worth $16.3M as of Q2 2026.
- BNP Paribas sold 8,933 Amgen shares in Q2 2026, an estimated $3.06M.
- Amgen made up 0.44% of BNP Paribas's portfolio in Q2 2026, its #44 holding.
- BNP Paribas first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
- BNP Paribas's Amgen position peaked at $19M in Q1 2026.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.